Skip to content
Screener

Cumberland Pharmaceuticals CPIX Share Repurchase Program, Authorized, Amount

Share Repurchase Program, Authorized, Amount at other companies

Viatris logo
ViatrisVTRS
$2B

Other financials

Income statement

See full
Revenue$166.5K-56.3%
Gross profit$7.2M-30.0%
Operating income-$3.2M-1.3%
Net income-$4.3M-477%
EPS (diluted)-$0.29-480%

Balance sheet

See full
Cash & equivalents$3.9M-76.0%
Total debt$4.7M-7.6%
Total equity$17.4M-37.7%
Total assets$62.9M-7.4%

Cash flow

See full
Operating cash flow$168.7K-80.0%
CapEx$38.3K+44.5%
Free cash flow$130.5K-84.0%

Valuation

See full
Market cap$116.87M+175%
Enterprise value$117.72M+274%
P/S3.7×+2.4×

Profitability

See full
Gross margin77.2%-7.1pp
Operating margin-30.8%+135pp
Net margin-34.9%-54.7pp
FCF margin2.2%

Returns & leverage

See full
Return on equity-48.1%-67.6pp
Debt / equity0.3×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The source filing: Cumberland Pharmaceuticals’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 5:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001087294-26-000062

On July 13, 2026, the Company's Board of Directors authorized and declared a special cash dividend of $1.50 per share of common stock payable in cash to the Company’s shareholders of record as of July 23, 2026. The dividend was paid on July 31, 2026 in the amount of $22.5 million. In addition to the special dividend, the Board authorized an open-market share repurchase program of up to $5 million in Cumberland shares of common stock over time. This replaces the previous share repurchase program established in January 2019 that allowed $10 million of share repurchases, of which $2.1 million remained available. The timing and actual number of shares repurchased pursuant the Company’s repurchase program will be determined by management depending on a variety of factors, including stock price, trading volume, market conditions, and other general business considerations. Several Board members will also be establishing new share purchase plans to increase their holdings in the Company.

Item 1. Financial Statements (Unaudited)

FAQ

What is Cumberland Pharmaceuticals's share repurchase program, authorized, amount?
Cumberland Pharmaceuticals (CPIX) reported share repurchase program, authorized, amount of $5 in Q2 2026.
What does share repurchase program, authorized, amount mean?
Share Repurchase Program, Authorized, Amount

Ask your AI about Cumberland Pharmaceuticals's share repurchase program, authorized, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude